Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy.
Polycystin-2 immunolocalization and function in zebrafish.
Tiotropium Bromide
Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.
View in:
PubMed
subject areas
Aged
Alanine
Antineoplastic Agents
Biomarkers, Tumor
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms
Prognosis
Survival Rate
Triazines
Withholding Treatment
authors with profiles
Robin Jones